Recent ARQT News
- Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc. • GlobeNewswire Inc. • 07/29/2024 11:35:00 AM
- Arcutis Launches ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis • GlobeNewswire Inc. • 07/29/2024 11:30:00 AM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 07/24/2024 08:10:33 PM
- Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Foam to the FDA for the Treatment of Scalp and Body Psoriasis in Adults and Adolescents Ages 12 and Over • GlobeNewswire Inc. • 07/23/2024 12:00:00 PM
- Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL • GlobeNewswire Inc. • 07/22/2024 12:00:00 PM
- FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age • GlobeNewswire Inc. • 07/09/2024 08:53:01 PM
- Arcutis Provides Update on sNDA for Roflumilast Cream 0.15% for Atopic Dermatitis • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/03/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:52:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:51:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2024 08:51:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:47:53 PM
- Arcutis Announces New Long-Term Data of Roflumilast Cream 0.15% for the Treatment of Mild to Moderate Atopic Dermatitis (AD) in Adults and Children Down to Age Six Presented at Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference • GlobeNewswire Inc. • 06/10/2024 06:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:15:39 PM
- Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/05/2024 08:00:00 PM
- Arcutis Announces Multiple Abstracts, Including Oral Presentation, Accepted at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference • GlobeNewswire Inc. • 06/05/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/04/2024 06:03:33 PM
- Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/03/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2024 11:38:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 07:54:27 PM
- Arcutis Canada annonce l'acceptation aux fins d'examen par Santé Canada de la présentation de la crème de roflumilast à 0,15 % pour le traitement de la dermatite atopique chez les adultes et les enfants âgés de 6 ans et plus • PR Newswire (Canada) • 05/28/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 09:12:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/17/2024 07:58:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:06:16 PM
- Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2024 08:00:00 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM